- Cell Based Approaches
- Chondrocyte Transplantation
- Growth Factor Technology
- Stem Cells
- Non-Cell Based Approaches
- Tissue Scaffolds
- Cell-free Composites
Knee Cartilage Repairing Market size was valued at USD 4.1 billion in 2023 and is expected to grow at a CAGR of 7.8% from 2024 to 2030. Cartilage is the rubbery and soft material present in bone joints and prevents friction between the bones. The Knee cartilage repairing market available in the market includes fibrocartilage, articular cartilage, and elastic cartilage. Knee cartilage damage mainly occurs due to osteoarticular disease, various physiological conditions, and accidents. Damage to the cartilage restricts normal movements of the knee causing pain and often occurs after traumatic and twisting injuries of the knee. Cartilage repair is beneficial for conditions like delayed unions, slow healing wounds, and malunions. The knee cartilage repair market is growing at a significant CAGR due to the increase in the geriatric population. The increase in the obese population, rising incidence of sports injuries, osteoarthritis, and chondrodystrophic leading are the major factors driving the growth of the market over the forecast period. Technological advancements, the rise in number of accidents & related injuries, and increasing demand for minimally invasive surgical products are the key factors boosting the growth of the market. However, the high cost of therapy and unfavorable reimbursement scenario are the major restraining factors of the market. Complexities of cartilage repair surgeries are also expected to hamper the growth of the knee repairing market over the forecast period.
Knee Cartilage Repairing Market Key Developments:
- In December 2016, FDA approved the autologous cultured chondrocytes on porcine collagen membrane (Maci) by Vericel corporation for symptomatic repair, full-thickness cartilage defects of knee in the adults
- In September 2014, DePuy Synthes inked an agreement with Blue Belt Technologies, Inc to access the Sigma HP partial knee on Navio surgical system
Global Knee Cartilage Repairing Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
7.8%
Largest Market
North-America
Fastest Growing Market
North America
Knee Cartilage Repairing Market Dynamics
Rising incidence and prevalence of obesity and diabetes is expected to propel the knee cartilage repairing market over the forecast period. According to the American Heart Association (AHA), the global geriatric population may be increased to 20% of the total population by 2030 which is expected to boost the cartilage repair market over the forecast period. Increase in the road accidents (according to World Health Organization, approximately 1.25 million people die each year in road accidents worldwide), and sports-related injuries (according to American Orthopaedic Society for Sports Medicine, more than 3.5 Mn athletes has received treatment due to sports injuries every year) are expected to fuel the knee cartilage repairing market over the forecast period. Developing technology in the knee cartilage repairing treatment also fuel the growth of the market. For instance, the German firm Amedrix GmbH has developed the minimally invasive surgical procedure for the treatment of cartilage defects.
North-America Got Significant Share
Knee Cartilage Repairing Market Regional Analysis
Geographically, knee cartilage repairing market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for a major revenue share in the global market followed by Europe. The factors which are responsible for the growth of knee cartilage repairing market in the region are an increase in geriatric population and rapid degenerative changes of the knees. Furthermore, the growth of the the market is partly driven by the expanded access to health insurance coverage in the U.S. through the Medicare and the Medicaid. Rise in prevalence of osteoporosis in France, U.K. (according to National Health Service, over 3 Mn people are affected to osteoporosis in the UK each year), and Germany is anticipated to bolster the knee cartilage repairing market in the Europe region. The presence of skilled healthcare professionals as well as rising bone and joint disorders expected to create the huge demand for surgery products in Germany. Asia Pacific is the most profitable region for knee cartilage repairing market owing to increase in the prevalence of diabetes (according to International Diabetes Federation 2015, approximately 109.6 Mn people were affected with diabetes in China, 1 Mn cases were reported Australia, and 7.2 Mn diabetes cases in Japan), rise in prevalence of osteoporosis in Australia and New Zealand (according to the Osteoporosis Australia over 1 Mn Australians and as per Burden of Osteoporosis in New Zealand (BONZ), the number osteoporosis at different sites in the skeleton was 84,000 cases in 2007, which is expected to reach 116,000 by 2020), increase in demand for elder care and treatment for age related conditions, and rise in medical tourism in Asia Pacific region anticipated to fuel the knee cartilage repairing market over the forecast period. Latin America and Middle East & Africa region are expected to fuel the demand for cartilage repair products during the forecast period due to increase in obese (overweight) population.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Knee Cartilage Repairing Market Segmentation
By Treatment Modality
By Application
- Hyaline Cartilage
- Fibrocartilage
By Procedure Type
- Arthroscopic Chondroplasty
- Osteochondral Grafts Transplantation
- Autologous Chondrocyte
- Implants Transplant
- Cell-based Cartilage Resurfacing
- Microfracture
- Others
By End User
- Hospitals
- Orthopaedic Clinics
- Ambulatory Surgical Centres
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The Knee cartilage repairing market size was valued at USD 4.1 billion in 2023
The Knee cartilage repairing market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The Knee cartilage repairing market key players are Medtronic (U.S.), Zimmer Biomet Inc.) (U.S.), ConMed Corporation (U.S.), Depuy Synthes (Johnson and Johnson Services, Inc.) (U.S.), Arthrex, Inc. (U.S.), Smith & Nephew PLC (U.K.), LifeNet Health, Inc. (U.S.), Anika Therapeutics, Inc. (U.S.), Stryker Corporation (U.S.), Vericel Corporation (U.S.)
| 1.Executive Summary |
| 2.Global Knee Cartilage Repairing Market Introduction |
| 2.1.Global Knee Cartilage Repairing Market - Taxonomy |
| 2.2.Global Knee Cartilage Repairing Market - Definitions |
| 2.2.1.Treatment Modality |
| 2.2.2.Application |
| 2.2.3.Procedure Type |
| 2.2.4.End User |
| 2.2.5.Region |
| 3.Global Knee Cartilage Repairing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Knee Cartilage Repairing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Knee Cartilage Repairing Market By Treatment Modality, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Cell Based Approaches |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Non-Cell Based Approaches |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Knee Cartilage Repairing Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Hyaline Cartilage |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Fibrocartilage |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Knee Cartilage Repairing Market By Procedure Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Arthroscopic Chondroplasty |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Osteochondral Grafts Transplantation |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Autologous Chondrocyte |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Implants Transplant |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Cell-based Cartilage Resurfacing |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Microfracture |
| 7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Others |
| 7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8.Global Knee Cartilage Repairing Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Orthopaedic Clinics |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Ambulatory Surgical Centres |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Knee Cartilage Repairing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Knee Cartilage Repairing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Treatment Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Cell Based Approaches |
| 10.1.2.Non-Cell Based Approaches |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hyaline Cartilage |
| 10.2.2.Fibrocartilage |
| 10.3. Procedure Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Arthroscopic Chondroplasty |
| 10.3.2.Osteochondral Grafts Transplantation |
| 10.3.3.Autologous Chondrocyte |
| 10.3.4.Implants Transplant |
| 10.3.5.Cell-based Cartilage Resurfacing |
| 10.3.6.Microfracture |
| 10.3.7.Others |
| 10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Orthopaedic Clinics |
| 10.4.3.Ambulatory Surgical Centres |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Knee Cartilage Repairing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Treatment Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Cell Based Approaches |
| 11.1.2.Non-Cell Based Approaches |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hyaline Cartilage |
| 11.2.2.Fibrocartilage |
| 11.3. Procedure Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Arthroscopic Chondroplasty |
| 11.3.2.Osteochondral Grafts Transplantation |
| 11.3.3.Autologous Chondrocyte |
| 11.3.4.Implants Transplant |
| 11.3.5.Cell-based Cartilage Resurfacing |
| 11.3.6.Microfracture |
| 11.3.7.Others |
| 11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Orthopaedic Clinics |
| 11.4.3.Ambulatory Surgical Centres |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Knee Cartilage Repairing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Treatment Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Cell Based Approaches |
| 12.1.2.Non-Cell Based Approaches |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hyaline Cartilage |
| 12.2.2.Fibrocartilage |
| 12.3. Procedure Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Arthroscopic Chondroplasty |
| 12.3.2.Osteochondral Grafts Transplantation |
| 12.3.3.Autologous Chondrocyte |
| 12.3.4.Implants Transplant |
| 12.3.5.Cell-based Cartilage Resurfacing |
| 12.3.6.Microfracture |
| 12.3.7.Others |
| 12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Orthopaedic Clinics |
| 12.4.3.Ambulatory Surgical Centres |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Knee Cartilage Repairing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Treatment Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Cell Based Approaches |
| 13.1.2.Non-Cell Based Approaches |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Hyaline Cartilage |
| 13.2.2.Fibrocartilage |
| 13.3. Procedure Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Arthroscopic Chondroplasty |
| 13.3.2.Osteochondral Grafts Transplantation |
| 13.3.3.Autologous Chondrocyte |
| 13.3.4.Implants Transplant |
| 13.3.5.Cell-based Cartilage Resurfacing |
| 13.3.6.Microfracture |
| 13.3.7.Others |
| 13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Orthopaedic Clinics |
| 13.4.3.Ambulatory Surgical Centres |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Knee Cartilage Repairing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Treatment Modality Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Cell Based Approaches |
| 14.1.2.Non-Cell Based Approaches |
| 14.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Hyaline Cartilage |
| 14.2.2.Fibrocartilage |
| 14.3. Procedure Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Arthroscopic Chondroplasty |
| 14.3.2.Osteochondral Grafts Transplantation |
| 14.3.3.Autologous Chondrocyte |
| 14.3.4.Implants Transplant |
| 14.3.5.Cell-based Cartilage Resurfacing |
| 14.3.6.Microfracture |
| 14.3.7.Others |
| 14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals |
| 14.4.2.Orthopaedic Clinics |
| 14.4.3.Ambulatory Surgical Centres |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Medtronic (U.S) |
| 15.2.2.Zimmer Biomet Inc.) (U.S) |
| 15.2.3.ConMed Corporation (U.S) |
| 15.2.4.Depuy Synthes (Johnson and Johnson Services, Inc) (U.S) |
| 15.2.5.Arthrex, Inc. (U.S) |
| 15.2.6.Smith & Nephew PLC (U.K) |
| 15.2.7.LifeNet Health, Inc. (U.S) |
| 15.2.8.Anika Therapeutics, Inc. (U.S) |
| 15.2.9.Stryker Corporation (U.S) |
| 15.2.10.Vericel Corporation (U.S) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Medtronic (U.S)
- Zimmer Biomet Inc.) (U.S)
- ConMed Corporation (U.S)
- Depuy Synthes (Johnson and Johnson Services, Inc) (U.S)
- Arthrex, Inc. (U.S)
- Smith & Nephew PLC (U.K)
- LifeNet Health, Inc. (U.S)
- Anika Therapeutics, Inc. (U.S)
- Stryker Corporation (U.S)
- Vericel Corporation (U.S)